RMI1
Basic information
Region (hg38): 9:83980798-84004074
Previous symbols: [ "C9orf76" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RMI1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 22 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 7 | 6 |
Variants in RMI1
This is a list of pathogenic ClinVar variants found in the RMI1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-84001041-C-T | Likely benign (Feb 01, 2023) | |||
9-84001044-G-A | not specified | Uncertain significance (Mar 28, 2024) | ||
9-84001057-C-T | not specified | Likely benign (Sep 09, 2021) | ||
9-84001105-A-C | not specified | Uncertain significance (Jan 17, 2024) | ||
9-84001134-A-G | not specified | Uncertain significance (Feb 21, 2024) | ||
9-84001224-G-A | not specified | Uncertain significance (Aug 17, 2022) | ||
9-84001258-C-T | not specified | Uncertain significance (Mar 07, 2024) | ||
9-84001260-T-G | not specified | Uncertain significance (Jan 24, 2024) | ||
9-84001416-G-A | not specified | Uncertain significance (Apr 04, 2024) | ||
9-84001437-T-A | not specified | Uncertain significance (May 26, 2024) | ||
9-84001441-A-G | not specified | Uncertain significance (Mar 16, 2022) | ||
9-84001452-A-G | not specified | Uncertain significance (Sep 12, 2023) | ||
9-84001463-T-G | not specified | Uncertain significance (Jun 03, 2022) | ||
9-84001504-T-C | not specified | Uncertain significance (Mar 25, 2024) | ||
9-84001507-C-G | not specified | Uncertain significance (Apr 23, 2024) | ||
9-84001512-C-T | not specified | Uncertain significance (Jun 30, 2023) | ||
9-84001528-T-C | RMI1-related disorder | Likely benign (Feb 22, 2022) | ||
9-84001536-C-A | not specified | Uncertain significance (Aug 02, 2022) | ||
9-84001578-T-C | RMI1-related disorder | Benign (Jan 06, 2020) | ||
9-84001596-G-C | not specified | Uncertain significance (Dec 01, 2022) | ||
9-84001609-C-T | not specified | Uncertain significance (Apr 08, 2022) | ||
9-84001687-A-G | not specified | Uncertain significance (Aug 15, 2023) | ||
9-84001693-T-C | not specified | Uncertain significance (Dec 13, 2023) | ||
9-84001824-A-G | not specified | Uncertain significance (Jun 22, 2024) | ||
9-84001836-A-G | RMI1-related disorder | Benign (Jun 30, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RMI1 | protein_coding | protein_coding | ENST00000325875 | 1 | 23360 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000366 | 0.949 | 125662 | 0 | 69 | 125731 | 0.000274 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.349 | 293 | 310 | 0.944 | 0.0000144 | 4126 |
Missense in Polyphen | 41 | 66.216 | 0.61918 | 874 | ||
Synonymous | 0.0450 | 113 | 114 | 0.995 | 0.00000552 | 1186 |
Loss of Function | 1.84 | 12 | 21.1 | 0.568 | 0.00000115 | 277 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000457 | 0.000456 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000276 | 0.000272 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000345 | 0.000343 |
Middle Eastern | 0.000276 | 0.000272 |
South Asian | 0.000396 | 0.000392 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Essential component of the RMI complex, a complex that plays an important role in the processing of homologous recombination intermediates to limit DNA crossover formation in cells. Promotes TOP3A binding to double Holliday junctions (DHJ) and hence stimulates TOP3A-mediated dissolution. Required for BLM phosphorylation during mitosis. Within the BLM complex, required for BLM and TOP3A stability. {ECO:0000269|PubMed:15775963, ECO:0000269|PubMed:16537486, ECO:0000269|PubMed:16595695}.;
- Pathway
- Fanconi anemia pathway - Homo sapiens (human);HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);DNA Repair;Gene expression (Transcription);DNA Double-Strand Break Repair;Generic Transcription Pathway;Homology Directed Repair;RNA Polymerase II Transcription;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;Fanconi anemia pathway;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Activity;Transcriptional Regulation by TP53;Cell Cycle;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Homologous DNA Pairing and Strand Exchange;Resolution of D-loop Structures through Holliday Junction Intermediates;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);Resolution of D-Loop Structures;HDR through Homologous Recombination (HRR)
(Consensus)
Recessive Scores
- pRec
- 0.0967
Intolerance Scores
- loftool
- 0.787
- rvis_EVS
- 0.67
- rvis_percentile_EVS
- 84.61
Haploinsufficiency Scores
- pHI
- 0.714
- hipred
- Y
- hipred_score
- 0.537
- ghis
- 0.540
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.960
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rmi1
- Phenotype
- homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype;
Gene ontology
- Biological process
- resolution of meiotic recombination intermediates;double-strand break repair via homologous recombination;reduction of food intake in response to dietary excess;DNA replication;response to glucose;multicellular organism growth;glucose homeostasis
- Cellular component
- nucleoplasm;nuclear body;RecQ helicase-Topo III complex
- Molecular function
- nucleotide binding;protein binding